These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3294015)

  • 21. [Experiences with ceftazidime in the therapy of neonatal infections].
    de Louvois J
    Infection; 1987; 15 Suppl 4():S209-13. PubMed ID: 3312037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Assessment of the efficacy of treating infections in hematopoietic proliferative diseases: Monotherapy with ceftazidime and tobramycin combined with amoxycillin/ampicillin].
    Koehler M; Bubała H; Sońta-Jakimczyk D; Wieczorek M; Janik-Moszant A; Kuder K
    Pol Tyg Lek; 1990 May 21-28; 45(21-22):417-20. PubMed ID: 2267192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tobramycin pharmacokinetics in premature identical twins during newborn period.
    Nahata MC; Durrell DE; Miller MA
    Dev Pharmacol Ther; 1986; 9(3):178-82. PubMed ID: 3709337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
    Blumer JL; Saiman L; Konstan MW; Melnick D
    Chest; 2005 Oct; 128(4):2336-46. PubMed ID: 16236892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tobramycin sulfate elimination in premature infants.
    Arbeter AM; Saccar CL; Eisner S; Sarni E; Yaffe SJ
    J Pediatr; 1983 Jul; 103(1):131-5. PubMed ID: 6864378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxic serum trough concentrations after administration of nebulized tobramycin.
    Kahler DA; Schowengerdt KO; Fricker FJ; Mansfield M; Visner GA; Faro A
    Pharmacotherapy; 2003 Apr; 23(4):543-5. PubMed ID: 12680485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
    J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo efficacy of humanised intermittent versus continuous ceftazidime in combination with tobramycin in an experimental model of pseudomonal pneumonia.
    Croisier D; Martha B; Piroth L; Chavanet P
    Int J Antimicrob Agents; 2008 Dec; 32(6):494-8. PubMed ID: 18804348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Society for Paediatric Infectious Diseases--Neonatal Sepsis Study Group.
    de Louvois J; Dagan R; Tessin I
    Eur J Pediatr; 1992 Dec; 151(12):876-84. PubMed ID: 1473540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of ceftazidime in the treatment of neonatal infections].
    Arimasu O; Hashira S; Fujii R
    Jpn J Antibiot; 1986 Aug; 39(8):2077-83. PubMed ID: 3540341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftazidime/clindamycin versus tobramycin/clindamycin in the treatment of intra-abdominal infections.
    Bubrick MP; Heim-Duthoy KL; Yellin AE; Berne TV; Heseltine PN; Appleman MD; Cocchetto DM; Matzke GR
    Am Surg; 1990 Oct; 56(10):613-7. PubMed ID: 2221611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic blood concentrations in patients successfully treated with tobramycin.
    Fiala M; Chatterjee SN
    Postgrad Med J; 1981 Sep; 57(671):548-51. PubMed ID: 7329892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.
    Permin H; Koch C; Høiby N; Christensen HO; Møller AF; Møller S
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():313-23. PubMed ID: 6352636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetic studies on ceftazidime in neonates].
    Nishimura T; Tabuki K; Takashima T
    Jpn J Antibiot; 1986 Aug; 39(8):2155-61. PubMed ID: 3540347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
    Janković B; Pasić S; Marković M; Veljković D; Milicić M
    Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceftazidime in septicaemia.
    Lundbergh P; Jarstrand C; Morfeldt-Månson L; Weiland O
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():199-205. PubMed ID: 6225764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose tobramycin combined with clindamycin or lincomycin in the treatment of septic peritonitis and intraabdominal sepsis.
    Muth L; Edén T
    Acta Chir Scand; 1981; 147(5):339-46. PubMed ID: 7324760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A successful antibiotic treatment by a new administration route: a case report of a subcutaneous administration of ceftazidime and tobramycin.
    Duron D; Chanoine S; Peron M; Lepelley M; Allenet B; Epaulard O; Camara B; Bedouch P
    Fundam Clin Pharmacol; 2019 Dec; 33(6):703-706. PubMed ID: 31038766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of tobramycin monitoring in adolescent and adult patients with cystic fibrosis.
    Touw DJ; Vinks AA; Heijerman HG; Bakker W
    Ther Drug Monit; 1993 Feb; 15(1):52-9. PubMed ID: 8451782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.